Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Amazon Great Indian Festival 2020 - Electronics

| More

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Posted On: 2020-09-28 09:14:54

HeidelbergCement India (HEIM), part of global major HeidelbergCement Group, is a play on fast growing, better priced and highly consolidated Central India. HEIM's recent debottlenecking by >15% to 6.26mnte provides volume growth visibility in near term; while it intends to scale up its size in the medium term along with parent company's support. HEIM enjoys industry-leading +20% return ratios, as its EBITDA/te more than doubled over the past four years to Rs1,122/te in FY20 led by +6% realisation CAGR. Given no major organic expansion plans over FY21-22E, net cash is likely to increase to Rs6.8bn by FY22E from the current Rs1.6bn. We initiate with a BUY rating and target price of Rs230/share (7xSep'22E EV/E).

- Recent de-bottlenecking provides volume visibility; scouting for acquisitions: HEIM has mining leases in Amreli, Gujarat for proposed greenfield expansion but environmental clearance and land acquisition could take a couple of years. Recent de-bottlenecking of grinding capacity by >15% provides near-term volume visibility. HEIM remains open for any acquisition, which could be funded via parent's support.

- Parent company support growth in India: Parent company HeidelbergCement Group (HCG) also owns 100% stake in unlisted 7.2mnte South-based Zuari Cement (ZC), besides owning 69.4% stake in HEIM. In the past, HCG had part-funded capex needs of both HEIM and ZC and seems willing to invest in high-growth markets like India. Likely relaxation of mining regulations in future coupled with some stake sale in the prospective merged entity could pave the way for merger of ZC with HEIM in India and could more than double HEIM's capacities. Both companies are currently managed under the common leadership of Mr Jamshed Naval Cooper, MD & CEO.

- Key beneficiary of strong demand growth in Central India: Low per capita cement consumption in Central India (at <200kgs) vs all India average (~250kgs) augurs well for strong growth opportunity over medium term. Better rural housing demand, higher government spends on low-cost housing and infrastructure coupled with elections in UP in early 2022 would drive strong demand growth. HEIM enjoys ~9% market share in Central India and is likely to be a key beneficiary.

- Prices have grown at 6% CAGR over FY16-20E in Central India post UTCEM's acquisition of JPA's assets. With >82% utilisation and higher consolidation (top six companies having 85% market share), prices are likely to remain firm. Given capacity constraint, HEIM is likely to focus more on realisation & improve profitability.

- HEIM enjoys best-in-class margins: HEIM sells 100% blended cement with 85% trade volumes. Increasing share of premium products, commissioning of 5MW solar plants, improving blending ratio and rationalising fixed costs still remains profitability levers for HEIM. We expect HEIM's EBITDA/te to increase to Rs1,246/te by FY23E and model 14% PAT CAGR over FY20-23E. Valuation at 5.5xFY22E EV/E is attractive, in our view.

Shares of HEIDELBERGCEMENT INDIA LTD. was last trading in BSE at Rs.180.6 as compared to the previous close of Rs. 178. The total number of shares traded during the day was 6335 in over 346 trades.

The stock hit an intraday high of Rs. 182.45 and intraday low of 178.1. The net turnover during the day was Rs. 1139603.

Source: Equity Bulls

Click here to send ur comments or to

Amazon Great Indian Festival 2020 - Mobiles

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Reiterate ADD on Amara Raja Batteries - Pent-up demand leads to healthy 2Q - HDFC Securities

Maintain REDUCE on Titan - Reasonable print - HDFC Securities

REDUCE on RBL Bank - Some positives, but key concerns remain - HDFC Securities

Maintain REDUCE on Marico - Saffola shines with PCNO recovery, muted margin - HDFC Securities

Maintain ADD on Dr. Reddy's Labs - Good quarter, lower SG&A cost is encouraging - HDFC Securities

Piramal Enterprises - Acquisition of stake from JV partner - Angel Broking

Maintain BUY on Axis Bank - Provision buffers strengthened (further) - HDFC Securities

AU Small Finance Bank - Q2FY21 Result - Angel Broking

L&T - Q2FY21 - Angel Broking

RBL Bank - Q2FY21 Result - Angel Broking

Axis Bank - Q2FY21 Result - Angel Broking

Marico Ltd - Q2FY21 Result Update - YES Securities

Titan Company Ltd - Q2FY21 Result Update - YES Securities

Axis Bank Limited - Q2FY21 Result Update - YES Securities

RBL Bank Limited - Q2FY21 Result Update - YES Securities

Multi Commodity Exchange of India - Operating leverage aids strong EBITDA performance - ICICI Securities

Titan Company - Faster-than-expected recovery - ICICI Securities

Marico - Strong performance across portfolio - ICICI Securities

Heritage Foods - Lower procurement prices leading to highest EBITDA margin in past decade - ICICI Securities

Axis Bank - Strong core again utilised to create provisioning buffer - ICICI Securities

Supreme Industries - Beat on all counts - ICICI Securities

GSK Pharmaceuticals - Recovery from COVID-19 impact - ICICI Securities

Hero MotoCorp - Solid demand recovery expectations priced in - ICICI Securities

Cement - Demand / prices improve further in Oct'20 - ICICI Securities

CEAT - Replacement demand drives outperformance - ICICI Securities

Dr. Reddy's Laboratories - Outperformance continues - ICICI Securities

ICICI Prudential Life Insurance - VNB trajectory in-line despite YoY dip in protection in Q2 - ICICI Securities

Bharti Airtel - Q2FY21 Result Update - ICICI Securities

Marico - Q2FY21 Result Update - ICICI Securities

Larsen & Toubro - Q2FY21 First Cut - ICICI Securities

Sanofi India - Q3CY20 Company Update - ICICI Securities

Adani Ports and SEZ - Quant Pick - ICICI Securities

Nippon Life India AMC - Q2FY21 Result Update - ICICI Securities

Tata Motors - Q2FY21 Result Update - ICICI Securities

Derivatives Strategy - Mahanagar Gas - Positional Future - ICICI Securities

Supreme Industries - Q2FY21 First Cut - ICICI Securities

Dr Reddy's Laboratories - Q2FY21 First Cut - ICICI Securities

Marico Ltd - Q2FY21 First Cut - ICICI Securities

Apcotex Industries - Q2FY21 First Cut - ICICI Securities

V-Guard Industries - Q2FY21 First Cut - ICICI Securities

Titan Company - Q2FY21 First Cut - ICICI Securities

Navin Fluorine - Q2FY21 First Cut - ICICI Securities

PI Industries - Q2FY21 First Cut - ICICI Securities

L&T - Q2FY21 Earnings First Cut: Beat on EBITDA margins - YES Securities

Bharti Airtel - Q2FY21 result - Angel Broking

Dr.Reddy's Lab - Q2FY21 - Angel Broking

BUY on Mahindra & Mahindra Financial Services - Remains an inexpensive rural play - HDFC Securities

Radico Khaitan - Q2FY21 - Angel Broking

Maintain BUY on CDSL - Firing on all cylinders - HDFC Securities

REDUCE on Nippon Life India Asset Management - Market share stabilising - HDFC Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019